If you find yourself eating a meal and feeling genuinely hungry again an hour later, or youre counting down the minutes until your next snack, its worth paying attention
A new generation of oral tablets, multi-target agonists, and next-generation injectables is reshaping the competitive landscape at pace, with fresh regulatory approvals, pivotal Phase 3 data, and an expanding list of indications that stretches far beyond weight loss and type 2 diabetes
Most reported side effects are mild and temporary , with users occasionally experiencing: Injection site reactions : Redness, swelling, or localized discomfort Headaches or dizziness Gastrointestinal issues : Nausea or mild stomach discomfort These effects typically resolve on their own
Other at-risk groups include people with coeliac or Crohns disease, those who have had weight loss surgery, and those with atrophic gastritis or pernicious anaemia
Prescription drugs: Medications, like semaglutide, that require authorization from a healthcare provider to ensure safe and effective use